Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

Share Price is delayed by 15 minutes
Get Live Data
319.50    2.00 (0.63%)
Bid:
320.00
Ask:
320.50
Spread: 0.50 (0.156%)
Market Cap: £736.98m
CSN Live PriceLast checked at - London Stock Exchange

Intraday Chesnara Share Chart

Directorate Change

12 May 2021 07:00

RNS Number : 2977Y
Chesnara PLC
12 May 2021
 

CHESNARA plc

("Chesnara" or "the Company")

 

12 May 2021

 

LEI Number: 213800VFRMBRTSZ3SJ06

 

 

CHANGE OF DIRECTORSHIP PLANNED FOR CHESNARA PLC

 

Chesnara today announces John Deane's intended retirement from the Company. He will be stepping down as Group Chief Executive Officer by the end of the year.

 

Under John Deane's six-year leadership, the Company has paid its shareholders £171m in dividends and seen the EcV of the group increase by £220m to £637m at 31 December 2020.

 

Luke Savage, Chairman, said: "John has made a significant contribution to Chesnara during his tenure, not least to the group's excellent financial track record. He will continue at the helm for the intervening period and ensure that there is a seamless handover to his successor. Both John and I will carry on delivering and progressing the group's strategic objectives and initiatives. So, for our customers, shareholders, staff and other stakeholders, it will feel like 'business as usual' given Chesnara's continued commitment to its existing strategy."

 

John Deane, Chief Executive said: "After six years at Chesnara and supporting the chairmanship change from Peter Mason to Luke, the timing is right for me to retire. I am not winding down just yet and will enjoy continuing to work with the team to achieve a smooth transition while making sure the group keeps on delivering value to all of our stakeholders."

 

The Company is also announcing that it has identified Steve Murray as intended successor to the role of Chief Executive. Steve has over twenty years' experience within the life assurance industry and a well-established track record in M&A, wider commercial leadership roles and experience of growing a business in "1825", Standard Life's financial advisory business. He will be appointed as an Executive Director and take up the role of Group Chief Executive Officer of Chesnara. Steve leaves his role as Chief Commercial Officer at Royal London to join Chesnara.

 

Steve Murray, Chief Executive Designate said: "I am delighted to be joining Chesnara later this year. I look forward to working closely with John and the wider team in my step into the Group Chief Executive role as we look to build on the company's successful and well-established strategy. I am excited by the opportunities we have ahead of us."

 

 

 

There are no matters to disclose in accordance with LR 9.6.13. The Company will make further announcements in due course and provide additional details of Steve Murray's appointment.

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

For further information, please contact:

 

 

 

Roddy Watt

Director, Capital Markets

FWD

Forward thinking communications

 

T - 020 7280 0651

E - roddy.watt@fwdconsulting.co.uk 

 

 

Notes to Editors

Chesnara is a life and pensions company listed on the London Stock Exchange. It administers over one million policies and operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands, and as Movestic in Sweden.

 

Following a three-pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing profitable new business in Sweden and the Netherlands and by undertaking value-adding acquisitions of either companies or portfolios.

 

Consistent delivery of the Company strategy has enabled Chesnara to increase its dividend for 16 years in succession.

 

Further details are available on the Company's website (www.chesnara.co.uk).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAABMMTMTABTMB
Date   Source Headline
23rd Nov 20177:30 amRNSHolding(s) in Company
23rd Nov 20177:00 amRNSResult of External Audit Tender
7th Nov 20177:00 amRNSDirector/PDMR Shareholding
1st Nov 20174:06 pmRNSTotal Voting Rights
7th Sep 20177:34 amRNSStatement re: the Legacy Review
31st Aug 20177:00 amRNSHalf-year Report
17th Aug 20174:00 pmRNSHolding(s) in Company
8th Aug 20177:00 amRNSNotice of Results
2nd Aug 20177:00 amRNSTotal Voting Rights
18th May 20177:00 amRNSResult of AGM
28th Apr 20173:26 pmRNSDirector/PDMR Shareholding
18th Apr 20177:00 amRNSAnnual Financial Report & AGM Notice
11th Apr 20172:06 pmRNSSCILDON - new name for Legal & General Nederland
6th Apr 20177:00 amRNSCompletion of LGN acquisition
31st Mar 20177:00 amRNSFinal Results
30th Mar 20175:15 pmRNSAcquisition
6th Mar 201712:11 pmRNSNotice of Results
6th Jan 20177:00 amRNSHolding(s) in Company
19th Dec 20167:00 amRNSHolding(s) in Company
16th Dec 20164:56 pmRNSUpdate on Excess Applications
16th Dec 20162:15 pmRNSHolding(s) in Company
15th Dec 20168:00 amRNSAdmission of Shares
14th Dec 20167:00 amRNSDirectorate Change
13th Dec 20164:20 pmRNS2016 EGM Results, TVR and Director Dealing
13th Dec 20167:00 amRNSResults of Placing and Open Offer
24th Nov 20165:25 pmRNSPublication of a Prospectus
24th Nov 20167:01 amRNSProposed Acquisition and Placing
22nd Nov 20167:10 amRNSStatement regarding market speculation
22nd Nov 20167:00 amRNSStatement regarding press speculation
26th Oct 20167:00 amRNSDirectorate Change
29th Sep 201610:07 amRNSHolding(s) in Company
31st Aug 20167:00 amRNSHalf-year Report
30th Aug 20167:00 amRNSHolding(s) in Company
10th Aug 201612:17 pmRNSNotice of Results
4th Jul 201610:32 amRNSHolding(s) in Company
14th Jun 20164:30 pmRNSNotification of director share interest
25th May 20161:41 pmRNSHolding(s) in Company
19th May 20167:00 amRNSAppointment of new joint broker
19th May 20167:00 amRNSDirectorate Change
19th May 20167:00 amRNSResult of AGM
28th Apr 20162:32 pmRNSDirector/PDMR Shareholding
20th Apr 20167:00 amRNSAnnual Financial Report 2015 and AGM Notice
31st Mar 20167:00 amRNSFinal Results
24th Mar 20168:45 amRNSNotice of Results
11th Mar 20163:45 pmRNSHolding(s) in Company
3rd Mar 20168:34 amRNSStatement re Legacy Review
30th Nov 20151:56 pmRNSHolding(s) in Company
19th Nov 20157:00 amRNSInterim Management Statement
13th Oct 20156:17 pmRNSHolding(s) in Company
28th Aug 20157:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.